PGCX, management laying the ground for explosive growth. Keep an eye on this one!

I like your enthusiasm, I guess I dont understand others strategy if they hold 30 mil shares and want the stock to drop. As if losing money is their MO. Not you personally.

PGCX is looking better and better, spoke to some oil industry folks from the Ford Eagle shale this evening and described the surfactant. Without even mentioning a name all three gentlemen had heard there was a new product in early test phase that had shown the potential for substantial cost savings. They were not familiar with the name Kruud Kleen but all agreed it would be huge. I can see PGCX hitting $1 in due time.

what did I miss here, there is a sticky with your name on it from 8/18 saying you expect a massive run. Whats changed ?

wearable tech is a huge developing market, may not have been the type of news everyone was hoping for but none the less positive baby steps.

Patents are valued as an asset, or in other words what revenue a company could gain by acquiring a patent.

TCEL will always trade at what the market values the stock, if it traded higher back in 2013 then thats what the market determined the worth at that time. Pink stocks are much more prone to manipulation thus the reason they are seen as a very high risk, I'm sure you already know this.

for some reason you seem to think that because Casey gave his own MARKET valuation of 30 million that makes his patent worth 30 million. If this is the case then why is John Meredith trying to raise 2 million dollars for clinical trials in the US. If TCEL had a $30 million evaluation it would not be trading at a fraction of a penny. GLTU and everyone else invested.

Eagle Ford shale is in Texas and its booming right now, now that PGCX has exclusivity your looking at millions in new business.

someone just sold 10,000 shares for 29. Did someone need lunch money that bad.

your right I am not a good stock picker, but I do know how to evaluate companies. Cell therapy is a groundbreaking science but until the FDA approves TCEL's process you do not have a viable business. Like I've said before that does not mean this stock will not rise as is has in the past, just know what you hold.

Finally had time to respond to your question, the answer is zero unless TCEL begins clinical trials and gets their process approved in the US they have nothing but what they sell in stock. Now if they begin trials and are successful then yes they may at some point in the future be worth 30 to 300 million, the earliest possibly time frame is 3-6 years. Ride the stock for what it is but dont invest in TCEL hoping the company hits it big.

Its very simple your leading this board to believe TCEL is worth 30 million, its not its worth exactly what is in the filings. If it was worth 30 million it would be trading much higher, its not. Know what you have, open your eyes or do yourself a favor and contact John Meredith, I did and he will respond.

You need to stop distorting what TCEL is, what you are doing is giving potential new investors false information. Stop posting someones potential market valuation of $30 million and calling it TCEL's revenue. I am an MBA and understand exactly what I'm reading, if you or anyone else have any questions contact John Meredith. jwsmeredith@aol.com

Do your own DD, don not believe what other posters are writing.

Everyone needs to read the quarterly filing, its very clear what you have in TCEL:

TCEL is the division/lab in the US for Therapy Cells LTD that intends to conduct trials, TCEL has absolutely no interest in any patent as they are nothing more than a clinical trial facility. Currently TCEL has no current operations in the US, John Meredith is trying to raise $2 million to resume operations that ceased in Oct 2013. Once Meredith raises the 2 mil then and only then will Casey oversee clinical trials.

If you purchasing TCEL stock you are doing nothing more than helping John Meredith raise capital, do not expect a dividend for at least 3-5 years if John is successful.

Those that think anything other than what is written here need to contact John Meredith at jwsmeredith@aol.com

this is fantastic ! thanks for posting.

I would not worry about the SEC as they rarely get involved in pinks unless there are multiple complaints. The only problem with TCEL is that there were multiple complaints back when it traded as Diamond Information and it appears they even issued a warning to investors back in 2011. Your and every other investors concern should be with knowing what your holding, if your ok with trading paper based on rips and dips you'll be fine. If you are putting all your money in TCEL hoping for a huge payday based on an FDA approval you are looking at years until that is even a possibility.

All patents are filed in the country of protection there is not a worldwide patent.

You did see the quarterly filing correct ? TCEL is no where near 2 million.

TCEL does not own the patent in question outright and it does not appear to have an interest in it either, Transplantation has an interest but the current percentage is not clear. According to the patent filing TCEL has no stake in the patent referenced. You keep quoting a market valuation, that is nothing more than someones opinion of what something is worth. Thats like saying I think my business is worth 200 million but the best the market will bear if sold is just under one million.

From all the information I have seen it appears TCEL was attempting to conduct trials back in 2012 with Casey overseeing at that time, the NZ company and Transplantation were involved back in 2012. Being Casey has not been compensated since 2012 it appears he is no longer involved.

Please keep in mind those waiting for a payday based off of an FDA approval for anything TCEL begins trials on in the future, you are potentially looking at 1-3 years of trials. This could be upwards of 5 years in some cases when dealing with human trials. Once trials are completed getting a new product or procedure fast tracked through the FDA is another 3 years unless designated whats called a breakthrough therapy, typically BT's are reserved for cancer drugs etc. So once TCEL has secured financing to begin and sustain operations the entire trial for human use you are looking at 4-6 years at a minimum for a payday. Its much more likely you will have success flipping this stock just based on trading paper. Good luck to all those in TCEL!

Those planning to invest large amounts of money need to understand you are currently buying paper not into company, thats not to say this stock will not move north as investors control the pps. A few takes aways from the filing:

"Dr P Casey, formerly a Director of the Company, is a party to the worldwide patent (Note 10)" NO SUCH THING AS A WORLDWIDE PATENT

"October 2013 we had to cease trialing the process due to lack of available and sustainable funds.
The new initiative to generate investment into the company will allow us to recommence these trials and move towards
selling the product on the open market. As a result, the Company is still in development and approval stage." TCEL has ceased operations of trials as of 10/13, they are looking for $2 million to resume trials at some point in the future, they plan to do this by selling stock.

The positives here are that Casey was paid $10 million in stock back in 2012 to be a consultant and or Director, whether he still has a position in TCEL is not clear

ZAZA Energy its another ticker, not sure what is has to do with XUII. I hardly noticed a change in my port, looks like it was a 1/10 r/s.

whats the next resistance after 33 ? If you have L2.

I'm hitting the ask, wish I had more to put in right now.

Anyone know how to get even a sample of the product ?

I actually just received the same message from Meredith:

Thank you for your interest in Therapy Cells Inc
Please wait for the publication of the next quarterly statement due this week
Regards
John Meredith
CFO Therapy Cells Inc


-----Original Message-----
From: jeff scott <.com>
To: jwsmeredith <jwsmeredith@aol.com>
Sent: Tue, 19 Aug 2014 3:55
Subject: Relationship to Dr. Casey

Mr. Meredith,

As I'm sure you are aware many investors including myself are confusing TCEL with Therapy Cells 2000, can you please help me understand TCEL's relationship with Dr. Patrick Casey if there is one ?


Thank You in advance
Jeff

I have not attempted to contact anyone except Meredith by phone and email and Casey via linkedIn.

my company is private thus the reason I do not have to post any officers, if you are judging based on websites alone ask yourself why TCEL does not have one, why they dont have a lab if they are working on cell structure, why they dont have a working phone, and the most concerning to me is a CEO that does not respond to investor questions.

you keep confusing TCEL with the NZ company, TCEL currently has no patent, no lab, no office, no working phone number and the CEO very clearly issued his own press release stating the NZ company PR'ed about the patent and TCEL has been confused with them. The NZ company does appear to be the only company connected with the patent. I have contacted Casey through LinkedIn if he does respond I will gladly post his response.

according to Meredith and Casey's own LinkedIn profile Casey has nothing to do with TCEL, since you refuse to contact the man himself all I can tell you is good luck.

Would you go to a physician that had no medical office, no working phone, and use to sell jewelry three years prior before deciding to change his business model to healthcare ? I doubt it, thats exactly what your investing in with TCEL. You need to ask yourself how is TCEL working on anything related to cell structure without an office or much less a lab. If you choose to believe a recent PR even when your own CEO has said they are coming from another company then thats your own choice. Your assumptions may be correct but there are way to many red flags and questions that have not been answered. I urge everyone to contact Casey to find out his relation to TCEL, please do your own DD and do not rely on someone else.

Here is a link to the patent TCEL PR'ed a year ago but was filed by Transplantation Limited appears to be a NZ company in Feb 2013, notice all related to the patent are in NZ and the owner of the patent Transplantation Limited is also located in NZ. The only problem I see with the patent is that TCEL is not listed.
http://www.google.com/patents/US8372644

According to Casey's own information he is not now or has ever been connected with TCEL, if you want answers from Casey I suggest you contact him. I have given you plenty of information which should make you concerned enough to contact both Meredith and Casey.

If you agree Meredith is the CEO in the company TCEL you have invested in then this alone should be reason enough to contact him and get an explanation of what is going on.


http://www.otcmarkets.com/otciq/ajax/showNewsReleaseDocumentById.pdf?id=10492

according to this link Diamond was a jewelry wholesaler, so far there is no information Casey was ever involved with Diamond as two other gentlemen are listed as officers.

http://www.insidermonkey.com/insider-trading/company/diamond+information+institute/1429859/

There may be more information on Diamond's organizational chart but I have yet to find it.

moral of the story is check with the man himself rather than believing everything you read. If he confirms he is involved with TCEL and they are currently working on cell restructuring at some undisclosed location then the relationship between the two will become clear.

you need to think about what your saying, you think Casey took over Diamond Information and just changed the name. He would have to been invoked with Diamond from day one. Diamond was not a Biotech company and Casey was never involved with the company unless he was a low level employee that dealt with precious stones. Everyone should do their own DD but I would at least suggest you check with Casey and get all the facts.

You may have missed the point here, Dr. Casey is still involved with Therapy Cells 2000 the NZ company according to his own LinkedIn profile,why he does not mention TCEL is beyond me and needs to be addressed as it has become clear the two companies are not related. I have yet to confirm Casey has or has ever had anything to do with TCEL which is run solely by someone named John Meredith, I have emailed Meredith but he has not responded. TCEL and John Meredith have no facility according to the last SEC filing, that was the first red flag for me. Most Biotech companies who work with microscopic cells at a granule level must have at least a class 1000 environment if not better. The second red flag was that TCEL was formally know as Diamond Information Institute, which looks as if it was was suspended the best I can tell. Link for name change: http://finance.yahoo.com/q/pr?s=TCEL+Profile

It would defiantly be a good idea to contact both Meredith and Casey to understand the relationship between the two.

I have no reason to get financially involved in this as I was not able confirm an office, telephone, website, or any revenue streams for TCEL other than selling shares. I would encourage all those who think TCEL holds any patent of Dr. Casey's to contact him through his LinkedIn page. Unless there are two Dr.Patrick Casey's this one has nothing to do with TCEL.

https://www.linkedin.com/pub/patrick-j-paddy-casey-o-casaigh/14/618/b7a

100% spot on, so Radly if your reading this do right by your investors.

Interesting how someone bought below the BID. Its getting hard to find positives when we have no solid news and a PPS that continues to plummet.

You do realize this is exactly what every single penny stock does to raise capital dont you ?

I hope it works out for you, good luck.